Sadhana Nitro Chem Ltd
Incorporated in 1973, Sadhana Nitro Chem Ltd manufactures chemical intermediates, heavy organic chemicals performance chemicals, and wireless network equipment and services[1]
- Market Cap ₹ 732 Cr.
- Current Price ₹ 2.45
- High / Low ₹ 5.88 / 1.27
- Stock P/E
- Book Value ₹ 1.54
- Dividend Yield 4.08 %
- ROCE -11.2 %
- ROE -23.6 %
- Face Value ₹ 1.00
Pros
- Company has reduced debt.
- Promoter holding has increased by 30.9% over last quarter.
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -14.8% over past five years.
- Company has a low return on equity of -8.69% over last 3 years.
- Company has high debtors of 1,275 days.
- Company's cost of borrowing seems high
- Promoter holding has decreased over last 3 years: -13.1%
- Working capital days have increased from 442 days to 939 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 48 | 35 | 57 | 110 | 267 | 120 | 90 | 121 | 146 | 189 | 133 | 41 | |
| 51 | 33 | 49 | 76 | 147 | 83 | 72 | 107 | 123 | 145 | 94 | 94 | |
| Operating Profit | -3 | 2 | 9 | 35 | 120 | 37 | 18 | 14 | 23 | 44 | 39 | -54 |
| OPM % | -7% | 6% | 15% | 32% | 45% | 31% | 20% | 11% | 16% | 23% | 30% | -133% |
| 13 | 0 | 0 | 0 | 1 | 2 | 4 | 5 | 2 | 4 | 3 | 8 | |
| Interest | 5 | 5 | 6 | 5 | 12 | 3 | 3 | 5 | 10 | 17 | 18 | 26 |
| Depreciation | 2 | 2 | 2 | 2 | 3 | 5 | 6 | 6 | 8 | 15 | 15 | 16 |
| Profit before tax | 3 | -5 | 1 | 28 | 106 | 31 | 13 | 8 | 7 | 16 | 9 | -88 |
| Tax % | -33% | 0% | 0% | -11% | 29% | 25% | 21% | 32% | 35% | 54% | 43% | -1% |
| 4 | -5 | 1 | 31 | 75 | 24 | 10 | 6 | 5 | 7 | 5 | -87 | |
| EPS in Rs | 0.01 | -0.02 | 0.00 | 0.11 | 0.26 | 0.08 | 0.04 | 0.02 | 0.02 | 0.02 | 0.02 | -0.29 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 51% | 66% | 50% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | -15% |
| 3 Years: | -35% |
| TTM: | -70% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -1773% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 33% |
| 5 Years: | -16% |
| 3 Years: | -53% |
| 1 Year: | -56% |
| Return on Equity | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | -5% |
| 3 Years: | -9% |
| Last Year: | -24% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 9 | 9 | 9 | 9 | 9 | 9 | 14 | 20 | 20 | 25 | 33 | 296 |
| Reserves | -7 | -12 | 2 | 37 | 95 | 114 | 119 | 145 | 208 | 208 | 251 | 160 |
| 37 | 42 | 36 | 16 | 8 | 46 | 83 | 116 | 139 | 233 | 247 | 113 | |
| 26 | 28 | 37 | 55 | 66 | 49 | 90 | 99 | 61 | 71 | 107 | 91 | |
| Total Liabilities | 66 | 68 | 83 | 116 | 179 | 218 | 306 | 380 | 428 | 536 | 639 | 661 |
| 31 | 29 | 37 | 39 | 67 | 76 | 70 | 67 | 144 | 156 | 149 | 163 | |
| CWIP | 9 | 9 | 9 | 11 | 2 | 15 | 23 | 68 | 28 | 53 | 100 | 78 |
| Investments | 0 | 0 | 0 | 0 | 5 | 6 | 6 | 7 | 6 | 6 | 2 | 0 |
| 26 | 30 | 37 | 66 | 105 | 122 | 207 | 238 | 250 | 321 | 387 | 420 | |
| Total Assets | 66 | 68 | 83 | 116 | 179 | 218 | 306 | 380 | 428 | 536 | 639 | 661 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6 | -1 | 10 | 44 | 52 | -11 | 1 | -4 | -38 | -2 | 48 | -31 | |
| -0 | -0 | -1 | -14 | -25 | -28 | -23 | -40 | -53 | -65 | -99 | -46 | |
| -6 | 2 | -6 | -14 | -23 | 30 | 30 | 46 | 72 | 41 | 34 | 93 | |
| Net Cash Flow | 0 | 0 | 4 | 16 | 4 | -8 | 7 | 2 | -19 | -26 | -16 | 16 |
| Free Cash Flow | 6 | -1 | 9 | 38 | 32 | -33 | -23 | -45 | -86 | -68 | -45 | -95 |
| CFO/OP | -182% | -49% | 115% | 132% | 51% | 19% | 8% | 32% | -145% | -3% | 131% | 53% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 58 | 135 | 83 | 25 | 46 | 156 | 236 | 121 | 200 | 282 | 363 | 1,275 |
| Inventory Days | 99 | 177 | 174 | 192 | 197 | 374 | 641 | 695 | ||||
| Days Payable | 220 | 401 | 321 | 122 | 141 | 197 | 273 | 357 | ||||
| Cash Conversion Cycle | -63 | -89 | -64 | 95 | 103 | 333 | 604 | 121 | 200 | 282 | 363 | 1,613 |
| Working Capital Days | -212 | -326 | -120 | -73 | 35 | 86 | 121 | 85 | 210 | 191 | 195 | 939 |
| ROCE % | -13% | 1% | 17% | 62% | 135% | 24% | 8% | 5% | 5% | 8% | 5% | -11% |
Insights
In beta| Mar 2013 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Export Sales Percentage % |
|
|||||||||||
| Number of Employees Number |
||||||||||||
| Meta Amino Phenol (MAP) Installed Capacity TPA |
||||||||||||
| ODB2 Installed Capacity TPA |
||||||||||||
| Nitrobenzene (NB) Installed Capacity TPA |
||||||||||||
| Para Amino Phenol (PAP) Installed Capacity TPA |
||||||||||||
| Energy Intensity GJ/MT |
||||||||||||
| Exported Chemicals MT |
||||||||||||
| Water Intensity KL/MT |
||||||||||||
| R&D Expenditure (Percentage of Turnover) % |
||||||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement Under Regulation 30 (LODR) - Issue And Allotment Of 6,75,00,000 Equity Shares Having Face Value Of Re. 1 Each On A Preferential Basis
2d - 6.75 crore preferential shares allotted at ₹2.06, floor price ₹2.05.
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
29 May - Annual secretarial compliance report for FY ended 31 March 2026 notes multiple LODR violations and fines.
-
Announcement Under Regulation 30 (LODR) - Long Term Supply Contract
28 May - Signed two-year Japanese export supply contract worth about Rs. 108 crore; order book exceeds Rs. 200 crore.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
28 May - Copies of Newspaper publication of Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2026 in Financial Express and Mumbai …
-
Statement Of Deviation Or Variation Of Funds Utilised Through The Rights Issue For The Quarter Ended March 31, 2026
26 May - No deviation in use of Rs. 263.53 crore rights issue proceeds for quarter ended March 31, 2026.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1][2]
SNCL is an ISO 9001:2015 certified and a government-recognized 2-Star Golden Export House. It is in the business of chemical and chemical products, pharma, medicinal chemicals, and intermediates